RCT of bumetanide in hypokalaemic periodic paralysis (HypoPP) using abductor digiti minimi compound muscle action potential (CMAP) as an objective outcome measure
2014 ◽
Vol 125
(10)
◽
pp. 2134-2135
◽
2012 ◽
Vol 78
(Meeting Abstracts 1)
◽
pp. P01.199-P01.199
1997 ◽
Vol 103
(1)
◽
pp. 208
1997 ◽
Vol 20
(9)
◽
pp. 1207-1208
◽